Literature DB >> 33494792

A bioavailable form of curcumin, in combination with vitamin-D- and omega-3-enriched diet, modifies disease onset and outcomes in a murine model of collagen-induced arthritis.

Mahadevappa Hemshekhar1, Vidyanand Anaparti1, Hani El-Gabalawy1,2,3, Neeloffer Mookherjee4,5.   

Abstract

OBJECTIVE: Curcumin (CUR), vitamin D3 (D3), and omega-3-fatty acids (O3FA) individually modulate inflammation and pain in arthritis. Although these supplements are widely used, their combinatorial effects have not been defined. In this study, we examined the effects of a D3 and O3FA (VO)-enriched diet in conjunction with a highly bioavailable form of CUR (Cureit/Acumin™) in a collagen-induced arthritis (CIA) murine model.
METHODS: Male DBA/1J mice were acclimatized to VO-enriched diet and challenged with bovine collagen II (CII). Bioavailable CUR was administered daily by oral gavage from the onset of CII challenge. Disease severity was determined by monitoring joint thickness and standardized clinical score. Cellular infiltration and cartilage degradation in the joints were assessed by histology, serum cytokines profiled by Meso Scale Discovery multiplex assay, and joint matrix metalloproteinases examined by western blots.
RESULTS: CUR by itself significantly decreased disease severity by ~ 60%. Administration of CUR in CIA mice taking a VO-enriched diet decreased disease severity by > 80% and maximally delayed disease onset and progression. Some of the disease-modifying effects was mediated by CUR alone, e.g., suppression of serum anti-collagen antibodies and decrease of cellular infiltration and MMP abundance in the joints of CIA mice. Although CUR alone suppressed inflammatory cytokines in serum of CIA mice, the combination of CUR and VO diet significantly enhanced the suppression (> 2-fold compared to CUR) of TNF, IFN-γ, and MCP-1, all known to be associated with RA pathogenesis.
CONCLUSION: This study provides proof-of-concept that the combination of bioavailable CUR, vitamin D3, and O3FA substantially delays the development and severity of CIA. These findings provide a rationale for systematically evaluating these widely available supplements in individuals at risk for developing future RA.

Entities:  

Keywords:  Collagen-induced arthritis; Curcumin; Inflammation; Omega-3; Rheumatoid arthritis; Vitamin D

Mesh:

Substances:

Year:  2021        PMID: 33494792      PMCID: PMC7836561          DOI: 10.1186/s13075-021-02423-z

Source DB:  PubMed          Journal:  Arthritis Res Ther        ISSN: 1478-6354            Impact factor:   5.156


  83 in total

Review 1.  Targeting the balance of T helper cell responses by curcumin in inflammatory and autoimmune states.

Authors:  Kaveh Rahimi; Abbas Ahmadi; Kambiz Hassanzadeh; Zahra Soleimani; Thozhukat Sathyapalan; Asadollah Mohammadi; Amirhossein Sahebkar
Journal:  Autoimmun Rev       Date:  2019-05-04       Impact factor: 9.754

Review 2.  Metalloproteinases in Rheumatoid Arthritis: Potential Therapeutic Targets to Improve Current Therapies.

Authors:  Yoshifumi Itoh
Journal:  Prog Mol Biol Transl Sci       Date:  2017-04-18       Impact factor: 3.622

3.  Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double-blind, controlled trial.

Authors:  Maryam Javadi; Hossein Khadem Haghighian; Sima Goodarzy; Mahnaz Abbasi; Marjan Nassiri-Asl
Journal:  Int J Rheum Dis       Date:  2019-09-03       Impact factor: 2.454

4.  Expression profiling of genes related to asthma exacerbations.

Authors:  T Aoki; Y Matsumoto; K Hirata; K Ochiai; M Okada; K Ichikawa; M Shibasaki; T Arinami; R Sumazaki; E Noguchi
Journal:  Clin Exp Allergy       Date:  2009-02       Impact factor: 5.018

5.  Curcumin attenuates sepsis-induced acute organ dysfunction by preventing inflammation and enhancing the suppressive function of Tregs.

Authors:  Longwang Chen; Yang Lu; Linjun Zhao; Lili Hu; Qiaomeng Qiu; Zhuoling Zhang; Mengfang Li; Guangliang Hong; Bing Wu; Guangju Zhao; Zhongqiu Lu
Journal:  Int Immunopharmacol       Date:  2018-05-17       Impact factor: 4.932

6.  Are dietary vitamin D, omega-3 fatty acids and folate associated with treatment results in patients with early rheumatoid arthritis? Data from a Swedish population-based prospective study.

Authors:  Cecilia Lourdudoss; Alicja Wolk; Lena Nise; Lars Alfredsson; Ronald van Vollenhoven
Journal:  BMJ Open       Date:  2017-06-10       Impact factor: 2.692

7.  Key Vitamin D Target Genes with Functions in the Immune System.

Authors:  Oona Koivisto; Andrea Hanel; Carsten Carlberg
Journal:  Nutrients       Date:  2020-04-19       Impact factor: 5.717

8.  Curcumin alleviates rheumatoid arthritis-induced inflammation and synovial hyperplasia by targeting mTOR pathway in rats.

Authors:  Qiaoding Dai; Di Zhou; Liping Xu; Xinwei Song
Journal:  Drug Des Devel Ther       Date:  2018-12-03       Impact factor: 4.162

9.  Efficacy of Curcumin with Iontophoretic Application on Paw Edema and Hematological Responses in Collagen-Induced Arthritis Rat Models.

Authors:  Ahmad Alghadir; Mohammad Miraj; Sharique Ali
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-09       Impact factor: 2.629

Review 10.  Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?

Authors:  Vasco Crispim Romão; Helena Canhão; João Eurico Fonseca
Journal:  BMC Med       Date:  2013-01-23       Impact factor: 8.775

View more
  2 in total

Review 1.  Edible Bioactive Film with Curcumin: A Potential "Functional" Packaging?

Authors:  Josemar Gonçalves Oliveira Filho; Mariana Buranelo Egea
Journal:  Int J Mol Sci       Date:  2022-05-18       Impact factor: 6.208

Review 2.  Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies.

Authors:  Anna-Lena Mueller; Zahra Payandeh; Niloufar Mohammadkhani; Shaden M H Mubarak; Alireza Zakeri; Armina Alagheband Bahrami; Aranka Brockmueller; Mehdi Shakibaei
Journal:  Cells       Date:  2021-11-04       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.